Steven M Hill Selected Research

Messenger RNA (mRNA)

9/2019	Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
6/2015	Melatonin: an inhibitor of breast cancer.
7/2014	Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night.
10/2011	Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.
9/2011	Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer.
12/2003	Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven M Hill Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 03/2002
26	Breast Neoplasms (Breast Cancer) 09/2019 - 03/2002
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2012
5	Neoplasm Metastasis (Metastasis) 11/2016 - 12/2009
3	Genomic Instability 06/2015 - 01/2014
2	Hyperinsulinism (Hyperinsulinemia) 03/2016 - 01/2014
2	Inflammation (Inflammations) 03/2016 - 11/2013
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Dementia (Dementias) 01/2021
1	Pathologic Complete Response 09/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Experimental Liver Neoplasms 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 03/2016
1	Leiomyosarcoma 03/2016
1	Body Weight Changes 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Hyperglycemia 01/2014
1	Obesity 11/2013
1	Prostatic Intraepithelial Neoplasia 05/2012
1	Adenocarcinoma 05/2012
1	Triple Negative Breast Neoplasms 01/2012

Drug/Important Bio-Agent (IBA)

31	MelatoninIBA 04/2024 - 03/2002
8	MT1 Melatonin ReceptorIBA 04/2024 - 05/2005
8	Linoleic Acid (Linoleate)IBA 01/2021 - 05/2011
8	Estrogen Receptor alphaIBA 08/2015 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 09/2017 - 05/2005
7	Estrogen ReceptorsIBA 08/2014 - 12/2003
6	Phosphotransferases (Kinase)IBA 09/2019 - 04/2012
6	Messenger RNA (mRNA)IBA 09/2019 - 12/2003
5	Estrogens (Estrogen)FDA Link 10/2011 - 05/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2005
4	Hormones (Hormone)IBA 01/2014 - 03/2002
4	Melatonin Receptors (Melatonin Receptor)IBA 10/2011 - 06/2002
3	Transcription Factors (Transcription Factor)IBA 09/2019 - 08/2015
3	Interleukin-17 (Interleukin 17)IBA 03/2016 - 05/2012
3	Glycogen Synthase KinasesIBA 03/2016 - 05/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 05/2011
3	CarcinogensIBA 07/2014 - 10/2010
3	13-hydroxy-9,11-octadecadienoic acidIBA 04/2012 - 09/2011
2	Cell-Free Nucleic AcidsIBA 04/2024 - 10/2022
2	Interleukin-6 (Interleukin 6)IBA 09/2019 - 11/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2019 - 08/2015
2	Tamoxifen FDA LinkGeneric 09/2019 - 08/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2019 - 01/2012
2	PhosphoproteinsIBA 04/2016 - 01/2015
2	Interleukin-17 ReceptorsIBA 03/2016 - 05/2012
2	Insulin (Novolin)FDA Link 03/2016 - 11/2013
2	Tyrosine (L-Tyrosine)FDA Link 08/2015 - 08/2014
2	Retroelements (Retrotransposon)IBA 06/2015 - 01/2014
2	p38 Mitogen-Activated Protein KinasesIBA 02/2013 - 01/2010
2	Urea (Carbamide)FDA LinkGeneric 02/2013 - 10/2010
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 02/2013 - 03/2002
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2012 - 05/2011
2	Glucose (Dextrose)FDA LinkGeneric 04/2012 - 05/2011
2	Adenosine Monophosphate (AMP)IBA 10/2011 - 11/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 05/2011 - 11/2008
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2009 - 11/2008
2	Estrogen Receptor betaIBA 11/2008 - 12/2003
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2008 - 05/2005
1	hydroxyoctadecadienoic acidIBA 01/2021
1	Fish OilsIBA 01/2021
1	Docosahexaenoic AcidsIBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	ThymidineIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	MethyltransferasesIBA 09/2019
1	Sirtuin 1IBA 09/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2019
1	fascinIBA 11/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2016
1	Glycogen Synthase Kinase 3IBA 03/2016
1	Cytostatic AgentsIBA 06/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Estrogen Receptor Modulators (Antiestrogen)IBA 08/2014
1	ProteomeIBA 05/2014
1	AntibodiesIBA 05/2014
1	LipidsIBA 01/2014
1	Insulin-Like PeptidesIBA 11/2013
1	EnzymesIBA 11/2012
1	CateninsIBA 11/2012
1	InterleukinsIBA 05/2012
1	MitogensIBA 04/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2012
1	methylselenic acidIBA 01/2012
1	SeleniumIBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 05/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2011
1	Mitogen-Activated Protein KinasesIBA 05/2011
1	Histones (Histone)IBA 05/2011
1	Nonesterified Fatty Acids (NEFA)IBA 05/2011
1	Cholesterol Esters (Cholesteryl Esters)IBA 05/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2011

Therapy/Procedure

4	Therapeutics 09/2019 - 01/2012
2	Drug Therapy (Chemotherapy) 04/2024 - 08/2015
1	Secondary Prevention 01/2021
1	Operative Surgical Procedures 04/2012
1	Intraperitoneal Injections 01/2012